Factors associated with patient and healthcare system delay in diagnosis and treatment of tuberculosis
Patient and healthcare system delays
DOI:
https://doi.org/10.22122/cdj.v11i2.471Keywords:
Tuberculosis, Diagnosis, Treatment, Cardiometabolic Risk Factors, DelayAbstract
BACKGROUND: More than 90% of the worldwide tuberculosis (TB) cases and deaths arise in the developing world. Delay in the diagnosis and treatment of TB potentially extents and aggravates the infection in the public leading to increased risk of death. Identifying the delays in the diagnosis of TB is indispensable to the health system to prevent spread of the disease. The current study was conducted to identify the factors related to patients and health care systems which delay diagnosis and treatment of TB in Qom Province, Iran.
METHODS: A cross-sectional survey was conducted on 661 patients with TB registered in healthcare units of Qom during 7 years (April 2011 to March 2017). Data regarding the patients’ demographic characteristics and clinical factors associated with diagnosis and treatment delay and total delay were analyzed using Student’s t-test and one-way analysis of variance (ANOVA). Multivariate logistic regression was also employed to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) using SPSS software.
RESULTS: The means of patient, healthcare, treatment, and total delay were 27.7 days, 53.7 days, 1.64 days, and 82.5 days, respectively. Additionally, 550 (83.2%) cases had total delay. It was determined that inhabitance, nationality, and type of extrapulmonary TB were significantly associated with diagnosis delay (P < 0.05).
CONCLUSION: Diagnostic delay in this study was mainly due to healthcare systems' facilities. Modern and efficient facilities would contribute a lot to early diagnosis of TB and improve the quality of TB management.
References
Bunyasi EW, Schmidt BM, Abdullahi LH, Mulenga H, Tameris M, Luabeya A, et al. Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: A systematic review protocol. BMJ Open. 2017; 7(3): e014609.
Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, et al. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet. 2019; 393(10178): 1331-84.
World Health Organization. Global Tuberculosis Report, United States 2019 [Online]. [cited 2019]; Available from: URL: https://data.worldbank.org/indicator/SH.TBS.INCD/.
Awoke N, Dulo B, Wudneh F. Total delay in treatment of tuberculosis and associated factors among new pulmonary TB patients in selected health facilities of Gedeo Zone, Southern Ethiopia, 2017/18. Interdiscip Perspect Infect Dis. 2019; 2019: 2154240.
Farzianpour F, Kooshad MA. Study of the status of tuberculosis control program based on the implementation of the directly observed treatment short-course strategy (DOTS). Mater Sociomed. 2016; 28(4): 249-52.
Paramasivam S, Thomas B, Chandran P, Thayyil J, George B, Sivakumar CP. Diagnostic delay and associated factors among patients with pulmonary tuberculosis in Kerala. J Family Med Prim Care. 2017; 6(3): 643-8.
Yazdani-Charati J, Rezai MS, Fendereski A, Mohammadi S, Alipour N. Treatment delay and total delay among pulmonary tuberculosis patients in the north of Iran: Application survival data analysis. Tanaffos. 2017; 16(1): 13-21.
Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Delayed diagnosis and treatment of pulmonary tuberculosis in high-burden countries: A systematic review protocol. BMJ Open. 2019; 9(7): e029807.
Hassan Zadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E. Pattern of reported tuberculosis cases in iran 2009-2010. Iran J Public Health. 2013; 42(1): 72-8.
World Health Organization. WHO treatment guidelines for drugresistant tuberculosis. Geneva, Switzerland: WHO; 2016.
Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: Systematic review and meta-analysis. BMC Pulm Med. 2017; 17(1): 202.
Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: A systematic review and meta-analysis. BMC Med. 2013; 11: 156.
Osei E, Akweongo P, Binka F. Factors associated with DELAY in diagnosis among tuberculosis patients in Hohoe Municipality, Ghana. BMC Public Health. 2015; 15: 721.
Chen HG, Liu M, Jiang SW, Gu FH, Huang SP, Gao TJ, et al. Impact of diabetes on diagnostic delay for pulmonary tuberculosis in Beijing. Int J Tuberc Lung Dis. 2014; 18(3): 267-71.
Lee CH, Wang JY, Lin HC, Lin PY, Chang JH, Suk CW, et al. Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: A retrospective nationwide cohort study. BMC Infect Dis. 2017; 17(1): 449.
Saldana L, Abid M, McCarthy N, Hunter N, Inglis R, Anders K. Factors affecting delay in initiation of treatment of tuberculosis in the Thames Valley, UK. Public Health. 2013; 127(2): 171-7.
Atre SR, Kudale AM, Morankar SN, Rangan SG, Weiss MG. Cultural concepts of tuberculosis and gender among the general population without tuberculosis in rural Maharashtra, India. Trop Med Int Health. 2004; 9(11): 1228-38.
Odusanya OO, Babafemi JO. Patterns of delays amongst pulmonary tuberculosis patients in Lagos, Nigeria. BMC Public Health. 2004; 4: 18.
Shiferaw MB, Zegeye AM. Delay in tuberculosis diagnosis and treatment in Amhara state, Ethiopia. BMC Health Serv Res. 2019; 19(1): 1-8.
Makgopa S, Madiba S. Tuberculosis knowledge and delayed health care seeking among new diagnosed tuberculosis patients in primary health facilities in an urban district, South Africa. Health Serv Insights. 2021; 14: 11786329211054035.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
